SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Fluidigm Corporation (NASDAQ:FLDM) will report its third quarter 2014 financial results on October 30, 2014, after close of market.
Gajus Worthington, Fluidigm president and chief executive officer, and Vikram Jog, chief financial officer, will host a conference call at 2:00 p.m. PT (5:00 p.m. ET) on October 30, 2014, to discuss third quarter 2014 financial results and operating activities. A press release outlining the financial results will be publicly distributed prior to the call.
The Fluidigm conference call can be accessed by calling (877) 556-5248 (domestic toll-free) or (720) 545-0029 (international toll). There will be a Q&A period during the call.
Fluidigm will also provide a live stream of its Q3 2014 financial results conference call for investors at: http://investors.fluidigm.com/events.cfm. The link will not be active until 1:45 p.m. PT on October 30, 2014.
A telephone replay of the teleconference will be available 90 minutes after the end of the call at (855) 859-2056 (domestic toll-free), or (404) 537-3406 (international toll), access code 13962396. The conference call will also be archived on the Fluidigm investor’s page at: http://investors.fluidigm.com.
Fluidigm (NASDAQ:FLDM) develops, manufactures, and markets life science analytical and preparatory systems for growth markets such as single-cell biology and production genomics. We sell to leading academic institutions, clinical laboratories, and pharmaceutical, biotechnology, and agricultural biotechnology companies worldwide. Our systems are based on proprietary microfluidics and multi-parameter mass cytometry technology, and are designed to significantly simplify experimental workflow, increase throughput, and reduce costs, while providing excellent data quality. Fluidigm products are provided for Research Use Only. Not for use in diagnostic procedures.
For more information, please visit: www.fluidigm.com
Fluidigm and the Fluidigm logo are trademarks or registered trademarks of Fluidigm Corporation.